Dr Petra Thomas, MD - Medicare Pulmonary Disease in Frederick, MD

Dr Petra Thomas, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Frederick, Maryland. She went to Temple University School Of Medicine and graduated in 1990 and has 34 years of diverse experience with area of expertise as Pulmonary Disease. She is a member of the group practice Nova Pulmonary Critical Care And Sleep Associates Llc and her current practice location is 7211 Bank Ct, Frederick, Maryland. You can reach out to her office (for appointments etc.) via phone at (240) 215-6310.

Dr Petra Thomas is licensed to practice in Maryland (license number D48133) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1518957661.

Contact Information

Dr Petra Thomas, MD
7211 Bank Ct,
Frederick, MD 21703-8483
(240) 215-6310
Not Available



Physician's Profile

Full NameDr Petra Thomas
GenderFemale
SpecialityPulmonary Disease
Experience34 Years
Location7211 Bank Ct, Frederick, Maryland
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Petra Thomas attended and graduated from Temple University School Of Medicine in 1990
  NPI Data:
  • NPI Number: 1518957661
  • Provider Enumeration Date: 10/28/2005
  • Last Update Date: 09/22/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 6204829161
  • Enrollment ID: I20131127000947

Medical Identifiers

Medical identifiers for Dr Petra Thomas such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1518957661NPI-NPPES
A6950006OtherDCDC BS
010058937MedicaidVA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RP1001XInternal Medicine - Pulmonary Disease 0101235337 (Virginia)Secondary
207RP1001XInternal Medicine - Pulmonary Disease D48133 (Maryland)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Inova Fair Oaks HospitalFairfax, VAHospital
Stonesprings Hospital CenterDulles, VAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Nova Pulmonary Critical Care And Sleep Associates Llc20627812143

News Archive

Biodar Plus to provide INVO Bioscience's infertility treatments and distribute INVOcell device across Ukraine

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.

Lessons from USS Theodore Roosevelt on limiting shipborne COVID-19 outbreaks

A new study published on the preprint server medRxiv* in November 2020 discusses such a scenario in terms of various possible approaches. It suggests that a viable strategy could be evacuating everyone from the ship and extensive surveillance testing.

Octreotide inhibits HepG2 proliferation, study confirms

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.

Digital solution for a smart pregnancy

Wouldn't it be handy if you were able to record your baby's heartbeat or even take an ultrasound scan just using a smartphone app at home, without having to make an appointment to visit your obstetrician or go to the hospital, with all the additional travel and waiting time that entails? Technology is currently being developed which ought to make this possible in the near future.

Glaucoma risk increased by air pollution

The more polluted the air, the higher the risk is that those who live in that area will develop glaucoma, says an interesting new study from the UK, published today in the journal Investigative Ophthalmology and Visual Science.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Petra Thomas allows following entities to bill medicare on her behalf.
Entity NameRidgeline Physician Services Plc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952627119
PECOS PAC ID: 5799817250
Enrollment ID: O20100719000563

News Archive

Biodar Plus to provide INVO Bioscience's infertility treatments and distribute INVOcell device across Ukraine

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.

Lessons from USS Theodore Roosevelt on limiting shipborne COVID-19 outbreaks

A new study published on the preprint server medRxiv* in November 2020 discusses such a scenario in terms of various possible approaches. It suggests that a viable strategy could be evacuating everyone from the ship and extensive surveillance testing.

Octreotide inhibits HepG2 proliferation, study confirms

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.

Digital solution for a smart pregnancy

Wouldn't it be handy if you were able to record your baby's heartbeat or even take an ultrasound scan just using a smartphone app at home, without having to make an appointment to visit your obstetrician or go to the hospital, with all the additional travel and waiting time that entails? Technology is currently being developed which ought to make this possible in the near future.

Glaucoma risk increased by air pollution

The more polluted the air, the higher the risk is that those who live in that area will develop glaucoma, says an interesting new study from the UK, published today in the journal Investigative Ophthalmology and Visual Science.

Read more Medical News

› Verified 3 days ago

Entity NamePrivia Medical Group Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013042480
PECOS PAC ID: 4385682061
Enrollment ID: O20140603000011

News Archive

Biodar Plus to provide INVO Bioscience's infertility treatments and distribute INVOcell device across Ukraine

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.

Lessons from USS Theodore Roosevelt on limiting shipborne COVID-19 outbreaks

A new study published on the preprint server medRxiv* in November 2020 discusses such a scenario in terms of various possible approaches. It suggests that a viable strategy could be evacuating everyone from the ship and extensive surveillance testing.

Octreotide inhibits HepG2 proliferation, study confirms

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.

Digital solution for a smart pregnancy

Wouldn't it be handy if you were able to record your baby's heartbeat or even take an ultrasound scan just using a smartphone app at home, without having to make an appointment to visit your obstetrician or go to the hospital, with all the additional travel and waiting time that entails? Technology is currently being developed which ought to make this possible in the near future.

Glaucoma risk increased by air pollution

The more polluted the air, the higher the risk is that those who live in that area will develop glaucoma, says an interesting new study from the UK, published today in the journal Investigative Ophthalmology and Visual Science.

Read more Medical News

› Verified 3 days ago

Entity NamePulmonary Care Consultants Of Northern Va
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1487060950
PECOS PAC ID: 3678792447
Enrollment ID: O20140910001783

News Archive

Biodar Plus to provide INVO Bioscience's infertility treatments and distribute INVOcell device across Ukraine

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.

Lessons from USS Theodore Roosevelt on limiting shipborne COVID-19 outbreaks

A new study published on the preprint server medRxiv* in November 2020 discusses such a scenario in terms of various possible approaches. It suggests that a viable strategy could be evacuating everyone from the ship and extensive surveillance testing.

Octreotide inhibits HepG2 proliferation, study confirms

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.

Digital solution for a smart pregnancy

Wouldn't it be handy if you were able to record your baby's heartbeat or even take an ultrasound scan just using a smartphone app at home, without having to make an appointment to visit your obstetrician or go to the hospital, with all the additional travel and waiting time that entails? Technology is currently being developed which ought to make this possible in the near future.

Glaucoma risk increased by air pollution

The more polluted the air, the higher the risk is that those who live in that area will develop glaucoma, says an interesting new study from the UK, published today in the journal Investigative Ophthalmology and Visual Science.

Read more Medical News

› Verified 3 days ago

Entity NameNova Pulmonary Critical Care And Sleep Associates Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1932633682
PECOS PAC ID: 2062781214
Enrollment ID: O20170704000007

News Archive

Biodar Plus to provide INVO Bioscience's infertility treatments and distribute INVOcell device across Ukraine

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.

Lessons from USS Theodore Roosevelt on limiting shipborne COVID-19 outbreaks

A new study published on the preprint server medRxiv* in November 2020 discusses such a scenario in terms of various possible approaches. It suggests that a viable strategy could be evacuating everyone from the ship and extensive surveillance testing.

Octreotide inhibits HepG2 proliferation, study confirms

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.

Digital solution for a smart pregnancy

Wouldn't it be handy if you were able to record your baby's heartbeat or even take an ultrasound scan just using a smartphone app at home, without having to make an appointment to visit your obstetrician or go to the hospital, with all the additional travel and waiting time that entails? Technology is currently being developed which ought to make this possible in the near future.

Glaucoma risk increased by air pollution

The more polluted the air, the higher the risk is that those who live in that area will develop glaucoma, says an interesting new study from the UK, published today in the journal Investigative Ophthalmology and Visual Science.

Read more Medical News

› Verified 3 days ago

Entity NameSignify Health Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1689158487
PECOS PAC ID: 3274895263
Enrollment ID: O20210226002383

News Archive

Biodar Plus to provide INVO Bioscience's infertility treatments and distribute INVOcell device across Ukraine

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.

Lessons from USS Theodore Roosevelt on limiting shipborne COVID-19 outbreaks

A new study published on the preprint server medRxiv* in November 2020 discusses such a scenario in terms of various possible approaches. It suggests that a viable strategy could be evacuating everyone from the ship and extensive surveillance testing.

Octreotide inhibits HepG2 proliferation, study confirms

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.

Digital solution for a smart pregnancy

Wouldn't it be handy if you were able to record your baby's heartbeat or even take an ultrasound scan just using a smartphone app at home, without having to make an appointment to visit your obstetrician or go to the hospital, with all the additional travel and waiting time that entails? Technology is currently being developed which ought to make this possible in the near future.

Glaucoma risk increased by air pollution

The more polluted the air, the higher the risk is that those who live in that area will develop glaucoma, says an interesting new study from the UK, published today in the journal Investigative Ophthalmology and Visual Science.

Read more Medical News

› Verified 3 days ago

Entity NameNova Pulmonary Care Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1720719784
PECOS PAC ID: 2961887823
Enrollment ID: O20220914001042

News Archive

Biodar Plus to provide INVO Bioscience's infertility treatments and distribute INVOcell device across Ukraine

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.

Lessons from USS Theodore Roosevelt on limiting shipborne COVID-19 outbreaks

A new study published on the preprint server medRxiv* in November 2020 discusses such a scenario in terms of various possible approaches. It suggests that a viable strategy could be evacuating everyone from the ship and extensive surveillance testing.

Octreotide inhibits HepG2 proliferation, study confirms

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.

Digital solution for a smart pregnancy

Wouldn't it be handy if you were able to record your baby's heartbeat or even take an ultrasound scan just using a smartphone app at home, without having to make an appointment to visit your obstetrician or go to the hospital, with all the additional travel and waiting time that entails? Technology is currently being developed which ought to make this possible in the near future.

Glaucoma risk increased by air pollution

The more polluted the air, the higher the risk is that those who live in that area will develop glaucoma, says an interesting new study from the UK, published today in the journal Investigative Ophthalmology and Visual Science.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Petra Thomas is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Petra Thomas, MD
Po Box 1400,
Fairfax, VA 22038-1400

Ph: (703) 383-9543
Dr Petra Thomas, MD
7211 Bank Ct,
Frederick, MD 21703-8483

Ph: (240) 215-6310

News Archive

Biodar Plus to provide INVO Bioscience's infertility treatments and distribute INVOcell device across Ukraine

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.

Lessons from USS Theodore Roosevelt on limiting shipborne COVID-19 outbreaks

A new study published on the preprint server medRxiv* in November 2020 discusses such a scenario in terms of various possible approaches. It suggests that a viable strategy could be evacuating everyone from the ship and extensive surveillance testing.

Octreotide inhibits HepG2 proliferation, study confirms

Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.

Digital solution for a smart pregnancy

Wouldn't it be handy if you were able to record your baby's heartbeat or even take an ultrasound scan just using a smartphone app at home, without having to make an appointment to visit your obstetrician or go to the hospital, with all the additional travel and waiting time that entails? Technology is currently being developed which ought to make this possible in the near future.

Glaucoma risk increased by air pollution

The more polluted the air, the higher the risk is that those who live in that area will develop glaucoma, says an interesting new study from the UK, published today in the journal Investigative Ophthalmology and Visual Science.

Read more News

› Verified 3 days ago


Internal Medicine Doctors in Frederick, MD

Dr. Patrick Johannes Mansky, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1562 Opossumtown Pike, Frederick, MD 21702
Phone: 301-662-8477    
Gaffar A Syed, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 801 Toll House Ave, H4, Frederick, MD 21701
Phone: 301-698-9444    Fax: 301-695-4444
Dr. Kristin A Conley, DO
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 7211 Bank Ct, Frederick, MD 21703
Phone: 240-566-7830    
Mr. Lloyd E Halvorson, M.D.
Pulmonary Disease
Medicare: Not Enrolled in Medicare
Practice Location: 7115 Guilford Dr Ste 202, Frederick, MD 21704
Phone: 301-663-5922    
Dr. Jeffrey Nathan Cowen, M.D.
Pulmonary Disease
Medicare: Not Enrolled in Medicare
Practice Location: 915 Toll House Ave, Suite 308, Frederick, MD 21701
Phone: 301-663-5790    Fax: 301-698-6259
Dr. Michael Terry Sullivan, MD
Pulmonary Disease
Medicare: Medicare Enrolled
Practice Location: 22 S Market Street, Frederick, MD 21701
Phone: 301-682-5683    Fax: 301-682-3499
Kellen Mulhern, D.O.
Pulmonary Disease
Medicare: Medicare Enrolled
Practice Location: 7211 Bank Ct, Frederick, MD 21703
Phone: 240-215-6310    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.